Cipla Q3 PAT up 15% at Rs 328 cr

Domestic sales grew by 14% to Rs 1,199 crore during Q3 FY15

Cipla Limited has posted a growth of 15 per cent in its net profit for the December quarter to Rs 328 crore.

The consolidated net profit was Rs 284 crore for the quarter ended December 31, 2013.

The income from operations grew by 6.5 per cent to Rs 2,765 crore, up from Rs 2,596 crore.

Domestic sales grew by 14 per cent to Rs 1,199 crore during the quarter, up from Rs 1,050 crore a year ago, largely on account of growth in respiratory, anti-infectives, cardiac and gastro intestinal therapies.

Exports of formulations decreased by six per cent to Rs 1,275 crore from Rs 1,360 crore a year ago. On Thursday, shares of Cipla went up by four per cent, or Rs 25.9, to close at Rs 662 on the BSE.